# AIM ImmunoTech Inc.: Form 8-K, filed Sep 10, 2026

- Company: [AIM ImmunoTech Inc.](/companies/aim.md) (CIK 946644)
- Form: 8-K
- Filed: 2026-09-10
- Accepted by EDGAR: Sep 10, 2026, 16:35 ET
- Period: 2026-09-03
- Accession: 0001493152-26-042196
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/946644/000149315226042196/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/946644/000149315226042196/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/946644/000149315226042196/form8-k.htm

Filed Sep 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-042196. Last ingested by Listed: Nov 6, 2026, 14:07 ET. No prices; not investment advice.